BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/3/2025 9:13:09 AM | Browse: 19 | Download: 0
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Review |
| Article Title |
Clinical application and expansion of paclitaxel-coated balloons in coronary atherosclerotic disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
A-Xiu Huang, Hong-Ying Xie, Gang Luo, Le Hong, Yun-Long Zhou, Yun Wang and De-Kui Gao |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Mianyang Health Commission 2019 Scientific Research Encouragement Project |
201948 |
|
| Corresponding Author |
De-Kui Gao, Department of Cardiology, Jiangyou Second People's Hospital, No. 31 Juhui Road, Jiangyou 621701, Sichuan Province, China. 635651229@qq.com |
| Key Words |
Drug-coated balloon; Coronary artery disease; In-stent restenosis; Bifurcation lesion; Large blood vessel; Small blood vessel; Coronary artery dissection; Complication; Interventional treatment |
| Core Tip |
Drug-coated balloon (DCB) angioplasty plays a pivotal role in the interventional management of atherosclerotic cardiovascular disease. This review focuses on the application of paclitaxel DCBs in coronary artery stenosis, encompassing their use in in-stent restenosis, large or small vessel disease, bifurcation lesions, and other lesion types. Key topics include lesion preparation techniques, DCB delivery strategies, complication management, safety evaluations, and post-procedural dual antiplatelet therapy strategies. Additionally, the review explores cellular and molecular mechanisms underlying anti-atherosclerotic and anti-restenotic effects, including endothelial repair, inhibition of neointimal hyperplasia, and modulation of inflammatory pathways. Current challenges and future directions in optimizing DCB-based therapies are also discussed. |
| Citation |
Huang AX, Gao DK, Xie HY, Luo G, Hong L, Zhou YL, Wang Y. Clinical application and expansion of paclitaxel-coated balloons in coronary atherosclerotic disease. World J Cardiol 2025; In press |
 |
Received |
|
2025-04-30 07:54 |
 |
Peer-Review Started |
|
2025-04-30 07:54 |
 |
First Decision by Editorial Office Director |
|
2025-05-17 08:49 |
 |
Return for Revision |
|
2025-05-17 08:49 |
 |
Revised |
|
2025-05-30 02:32 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-01 02:52 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-03 09:13 |
 |
Articles in Press |
|
2025-12-03 09:13 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345